Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277–300.

    Article  Google Scholar 

  2. Loehrer PJ, Gonin R, Nichols CR, Weathers T, Einhorn LH . Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998; 16: 2500–2504.

    Article  CAS  Google Scholar 

  3. Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005; 23: 6549–6555.

    Article  CAS  Google Scholar 

  4. Nichols CR, Andersen J, Lazarus HM, Fisher H, Greer J, Stadtmauer EA et al. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 1992; 10: 558–563.

    Article  CAS  Google Scholar 

  5. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R . High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 2007; 357: 340–348.

    Article  CAS  Google Scholar 

  6. Motzer RJ, Mazumdar M, Sheinfeld J, Bajorin DF, Macapinlac HA, Bains M et al. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 2000; 18: 1173–1180.

    Article  CAS  Google Scholar 

  7. Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L et al. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol 2007; 25: 85–90.

    Article  CAS  Google Scholar 

  8. Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N et al. TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. J Clin Oncol 2010; 28: 1706–1713.

    Article  CAS  Google Scholar 

  9. International Prognostic Factors Study G, Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 2010; 28: 4906–4911.

    Article  Google Scholar 

  10. Lewin J, Dickinson M, Voskoboynik M, Collins M, Ritchie D, Toner G . High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients. Intern Med J 2014; 44: 771–778.

    Article  CAS  Google Scholar 

  11. Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R et al. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 2005; 16: 1152–1159.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P J Hayden.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O'Kane, G., Bracken-Clarke, D., Gardiner, N. et al. A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen. Bone Marrow Transplant 51, 856–859 (2016). https://doi.org/10.1038/bmt.2015.354

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.354

Search

Quick links